| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
Protein kinase C (PKC) is a family of serine/threonine kinases that is involved in the transduction of signals for cell proliferation and differentiation. The important role of PKC in processes relevant to neoplastic transformation, carcinogenesis and tumour cell invasion renders it a potentially suitable target for anticancer therapy. Furthermore, there is accumulating evidence that selective targeting of PKC may improve the therapeutic efficacy of established neoplastic agents and sensitise cells to ionising radiation. This article reviews the rationale for targeting PKC, focuses on its role in breast cancer and reviews the preclinical and clinical data available for the efficacy of PKC inhibition.
This article has been cited by other articles:
|
|
 |
|
  Y.-F. Chang, S. S. Martin, E. P. Baldwin, and G. M. Carman Phosphorylation of Human CTP Synthetase 1 by Protein Kinase C: IDENTIFICATION OF Ser462 AND Thr455 AS MAJOR SITES OF PHOSPHORYLATION J. Biol. Chem., June 15, 2007; 282(24): 17613 - 17622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Di Modugno, L. DeMonte, M. Balsamo, G. Bronzi, M. R. Nicotra, M. Alessio, E. Jager, J. S. Condeelis, A. Santoni, P. G. Natali, et al. Molecular Cloning of hMena (ENAH) and Its Splice Variant hMena+11a: Epidermal Growth Factor Increases Their Expression and Stimulates hMena+11a Phosphorylation in Breast Cancer Cell Lines Cancer Res., March 15, 2007; 67(6): 2657 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Buganim, E. Kalo, R. Brosh, H. Besserglick, I. Nachmany, Y. Rais, P. Stambolsky, X. Tang, M. Milyavsky, I. Shats, et al. Mutant p53 Protects Cells from 12-O-Tetradecanoylphorbol-13-Acetate-Induced Death by Attenuating Activating Transcription Factor 3 Induction. Cancer Res., November 15, 2006; 66(22): 10750 - 10759. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oster and M. Leitges Protein Kinase C {alpha} but not PKC{zeta} Suppresses Intestinal Tumor Formation in ApcMin/+ Mice. Cancer Res., July 15, 2006; 66(14): 6955 - 6963. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zhang, J. Huang, N. Yang, S. Liang, A. Barchetti, A. Giannakakis, M. G. Cadungog, A. O'Brien-Jenkins, M. Massobrio, K. F. Roby, et al. Integrative Genomic Analysis of Protein Kinase C (PKC) Family Identifies PKC{iota} as a Biomarker and Potential Oncogene in Ovarian Carcinoma. Cancer Res., May 1, 2006; 66(9): 4627 - 4635. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Patel, S. H. Ramkissoon, P. S. Patel, and P. Rameshwar Transformation of breast cells by truncated neurokinin-1 receptor is secondary to activation by preprotachykinin-A peptides PNAS, November 29, 2005; 102(48): 17436 - 17441. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Frogne, J S Jepsen, S S Larsen, C K Fog, B L Brockdorff, and A E Lykkesfeldt Antiestrogen-resistant human breast cancer cells require activated Protein Kinase B/Akt for growth Endocr. Relat. Cancer, September 1, 2005; 12(3): 599 - 614. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C Pequeux, B P Keegan, M-T Hagelstein, V Geenen, J-J Legros, and W G North Oxytocin- and vasopressin-induced growth of human small-cell lung cancer is mediated by the mitogen-activated protein kinase pathway Endocr. Relat. Cancer, December 1, 2004; 11(4): 871 - 885. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Koivunen, V. Aaltonen, S. Koskela, P. Lehenkari, M. Laato, and J. Peltonen Protein Kinase C {alpha}/{beta} Inhibitor Go6976 Promotes Formation of Cell Junctions and Inhibits Invasion of Urinary Bladder Carcinoma Cells Cancer Res., August 15, 2004; 64(16): 5693 - 5701. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
